Obermatt
See Similar Stocks →

MindMaze Therapeutics Holding

SWX:MMTX · CH1251125998
BiotechnologySmall

360

49
Profit price75
Owner Earnings Yield1
Dividend Yield1
Price/Sales26
EV / Gross Profit23
Price/Book84
Return on Capital52
Cash Return on Capital80
Return on Equity67
Profit margins42

Cash truth not applicable for financial companies.

Sales growth—
Profit growth46
Reinvestment26
Price momentum3
Debt load58
Refinancing26
Debt Payback1
Liquidity10
Analyst ratings—
Expectations trend50
Market mood3

Profile

CountrySwitzerland
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeSWX
Founded2025
Websiterelieftherapeutics.com
ISINCH1251125998
Last UpdateApr 2, 2026
Indices
SPI (Switzerland)
Themes
NeurologyPain ManagementAssistive TechnologyBiomedical EngineeringMHealthNeuroscienceWearables

Description

Analysis

Middle-of-the-road

MindMaze Therapeutics Holding SA is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

Valuation data is not available for this company.

The trajectory is moderate and the balance sheet is adequate. Analysts lean positive.

What to watch: A large part of the company's book value is the price paid for past acquisitions. As always: this describes the company's numbers; it is not a recommendation.

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
26
—
—
—
Price/Earnings
45
—
—
—
Price/Book
84
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
25
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare MindMaze Therapeutics Holding with its peers
Roivant Sciences
NSQ:ROIV
47
CountryUK
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Transgene
PAR:TNG
15
CountryFrance
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
AC Immune
NMQ:ACIU
68
CountrySwitzerland
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Idorsia
SWX:IDIA
14
CountrySwitzerland
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Kiniksa Pharmaceuticals
NSQ:KNSA
99
CountryUK
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Prothena Corporation
NSQ:PRTA
39
CountryIreland
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →